Leptin attenuates hypoxia/reoxygenation-induced activation of the intrinsic pathway of apoptosis in rat H9c2 cells

Journal of Cellular Physiology

Volumn 221, Issue 2, 2009, Pages 490-497

  Shin, Eyun Jung ^a   Schram, Kristin ^a   Zheng, Xi Long ^a,b   Sweeney, Gary ^a  

^a YORK UNIVERSITY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CASPASE 3; CYTOCHROME C; LEPTIN; LIPOCORTIN 5; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BAX; AMP ACTIVATED PROTEIN KINASE KINASE; AMP-ACTIVATED PROTEIN KINASE KINASE; OXYGEN; PHOSPHATIDYLSERINE; PROTEIN KINASE;

ANIMAL CELL; ANIMAL CELL CULTURE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA FRAGMENTATION; EMBRYO; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HYPOXIA; IMMUNOFLUORESCENCE TEST; LASER SCANNING CYTOMETRY; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; REOXYGENATION; ANIMAL; ANOXIA; CELL LINE; CELL PROTECTION; DRUG EFFECT; ENZYMOLOGY; METABOLISM; MITOCHONDRION; PATHOLOGY; PROTEIN BINDING; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

RATTUS;

ANIMALS; ANNEXIN A5; ANOXIA; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CELL LINE; CYTOCHROMES C; CYTOPROTECTION; DNA FRAGMENTATION; IN SITU NICK-END LABELING; LEPTIN; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; OXYGEN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLSERINES; PROTEIN BINDING; PROTEIN KINASES; PROTEIN TRANSPORT; RATS; SIGNAL TRANSDUCTION;

EID: 70149093942     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21883     Document Type: Article

References (44)

1. Abel ED, Litwin SE, Sweeney G. 2008. Cardiac remodeling in obesity. Physiol Rev 88:389-419.
2. Ahima RS, Flier JS. 2000. Leptin. Annu Rev Physiol 62:413-437.
3. Barouch LA, Gao D, Chen L, Miller KL, Xu W, Phan AC, Kittleson MM, Minhas KM, Berkowitz DE, Wei C, Hare JM. 2006. Cardiac myocyte apoptosis is associated with increased DNA damage and decreased survival in murine models of obesity. Circ Res 98:119-124. (Pubitemid 43970211)
4. Borutaite V, Brown GC. 2003. Mitochondria in apoptosis of ischemic heart. FEBS Lett 541:1-5.
5. Brown JE, Dunmore SJ. 2007. Leptin decreases apoptosis and alters BCL-2: Bax ratio in clonal rodent pancreatic beta-cells. Diabetes Metab Res Rev 23:497-502.
6. Bruno A, Conus S, Schmid I, Simon HU. 2005. Apoptotic pathways are inhibited by leptin receptor activation in neutrophils. J Immunol 174:8090-8096. (Pubitemid 40806320)
7. Capano M, Crompton M. 2006. Bax translocates to mitochondria of heart cells during simulated ischaemia: Involvement of AMP-activated and p38 mitogen-activated protein kinases. Biochem J 395:57-64.
8. Chapman RS, Chresta CM, Herberg AA, Beere HM, Heer S, Whetton AD, Hickman JA, Dive C. 1995. Further characterisation of the in situ terminal deoxynucleotidyl transferase (TdT) assay for the flow cytometric analysis of apoptosis in drug resistant and drug sensitive leukaemic cells. Cytometry 20:245-256.
9. Chen C, Chang YC, Liu CL, Liu TP, Chang KJ, Guo IC. 2007. Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway. Endocr Relat Cancer 14:513-529. (Pubitemid 47242649)
10. Condorelli G, Morisco C, Stassi G, Notte A, Farina F, Sgaramella G, de Rienzo A, Roncarati R, Trimarco B, Lembo G. 1999. Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes bax and bcl-2 during left ventricular adaptations to chronic pressure overload in the rat. Circulation 99:3071-3078. (Pubitemid 29270439)
11. Conus S, Bruno A, Simon HU. 2005. Leptin is an eosinophil survival factor. J Allergy Clin Immunol 116:1228-1234.
12. Danial NN, Korsmeyer SJ. 2004. Cell death: Critical control points. Cell 116:205-219. (Pubitemid 38167313)
13. Das M. 2007. Apoptosis as a therapeutic target in heart failure. Am J Physiol Heart Circ Physiol 293:H1322-1323.
14. Desbiens KM, Deschesnes RG, Labrie MM, Desfosses Y, Lambert H, Landry J, Bellmann K. 2003. c-Myc potentiates the mitochondrial pathway of apoptosis by acting upstream of apoptosis signal-regulating kinase 1 (Ask1) in the p38 signalling cascade. Biochem J 372:631-641. (Pubitemid 36723910)
15. Dong F, Ren J. 2007. Fitness or fatness-The debate continues for the role of leptin in obesity-associated heart dysfunction. Curr Diabetes Rev 3:159-164. (Pubitemid 47244060)
16. Eguchi M, Liu Y, Shin EJ, Sweeney G. 2008. Leptin protects H9c2 rat cardiomyocytes from H(2)O(2)-induced apoptosis. FEBS J 275:3136-3144.
17. Erkasap N, Ikizler M, Shneyvays V, Zinman T, Mamedova LK, Uyar R, Shainberg A. 2006. Leptin protects the cardiac myocyte cultures from hypoxic damage. Life Sci 78:1098-1102. (Pubitemid 43143467)
18. Fiorillo C, Ponziani V, Giannini L, Cecchi C, Celli A, Nassi N, Lanzilao L, Caporale R, Nassi P. 2006. Protective effects of the PARP-1 inhibitor PJ34 in hypoxic-reoxygenated cardiomyoblasts. Cell Mol Life Sci 63:3061-3071. (Pubitemid 46072308)
19. Foster KA, Galeffi F, Gerich FJ, Turner DA, Muller M. 2006. Optical and pharmacological tools to investigate the role of mitochondria during oxidative stress and neurodegeneration. Prog Neurobiol 79:136-171. (Pubitemid 44255860)
20. Gorczyca W, Bigman K, Mittelman A, Ahmed T, Gong J, Melamed MR, Darzynkiewicz Z. 1993. Induction of DNA strand breaks associated with apoptosis during treatment of leukemias. Leukemia 7:659-670. (Pubitemid 23186018)
21. Gordeladze JO, Drevon CA, Syversen U, Reseland JE. 2002. Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling. J Cell Biochem 85:825-836. (Pubitemid 34462792)
22. Gustafsson AB, Gottlieb RA. 2007. Bcl-2 family members and apoptosis, taken to heart. Am J Physiol Cell Physiol 292:C45-C51. (Pubitemid 46115120)
23. Gustafsson AB, Tsai JG, Logue SE, Crow MT, Gottlieb RA. 2004. Apoptosis repressor with caspase recruitment domain protects against cell death by interfering with Bax activation. J Biol Chem 279:21233-21238.
24. Habbu A, Lakkis NM, Dokainish H. 2006. The obesity paradox: Fact or fiction? Am J Cardiol 98:944-948.
25. Heusch G. 2006. Obesity-A risk factor or a RISK factor for myocardial infarction? Br J Pharmacol 149:1-3.
26. Hochhauser E, Kivity S, Offen D, Maulik N, Otani H, Barhum Y, Pannet H, Shneyvays V, Shainberg A, Goldshtaub V, Tobar A, Vidne BA. 2003. Bax ablation protects against myocardial ischemia-reperfusion injury in transgenicmice. Am J Physiol Heart Circ Physiol 284:H2351-H2359. (Pubitemid 36622451)
27. Hou Q, Hsu YT. 2005. Bax translocates from cytosol to mitochondria in cardiac cells during apoptosis: Development of a GFP-Bax-stable H9c2 cell line for apoptosis analysis. Am J Physiol Heart Circ Physiol 289:H477-H487. (Pubitemid 40934135)
28. Jung F, Weiland U, Johns RA, Ihling C, Dimmeler S. 2001. Chronic hypoxia induces apoptosis in cardiac myocytes: A possible role for Bcl-2-like proteins. Biochem Biophys Res Commun 286:419-425. (Pubitemid 32924931)
29. Li X, Traganos F, Melamed MR, Darzynkiewicz Z. 1995. Single-step procedure for labeling DNA strand breaks with fluorescein- or BODIPY-conjugated deoxynucleotides: Detection of apoptosis and bromodeoxyuridine incorporation. Cytometry 20:172-180.
30. Lopez-Neblina F, Toledo AH, Toledo-Pereyra LH. 2005. Molecular biology of apoptosis in ischemia and reperfusion. J Invest Surg 18:335-350. (Pubitemid 43123614)
31. Matsui H, Motooka M, Koike H, Inoue M, Iwasaki T, Suzuki T, Kurabayashi M, Yokoyama T. 2007. Ischemia/reperfusion in rat heart induces leptin and leptin receptor gene expression. Life Sci 80:672-680. (Pubitemid 46091791)
32. Myers MG, Cowley MA, Munzberg H. 2008. Mechanisms of leptin action and leptin resistance. Annu Rev Physiol 70:537-556.
33. Purdham DM, Rajapurohitam V, Zeidan A, Huang C, Gross GJ, Karmazyn M. 2008. A neutralizing leptin receptor antibody mitigates hypertrophy and hemodynamic dysfunction in the postinfarcted rat heart. Am J Physiol Heart Circ Physiol 295:H441-H446.
34. Regula KM, Kirshenbaum LA. 2005. Apoptosis of ventricular myocytes: A means to an end. J Mol Cell Cardiol 38:3-13.
35. Segers VF, Lee RT. 2008. Stem-cell therapy for cardiac disease. Nature 451:937-942.
36. Sirotkin AV, Grossmann R. 2007. Leptin directly controls proliferation, apoptosis and secretory activity of cultured chicken ovarian cells. Comp Biochem Physiol A Mol Integr Physiol 148:422-429. (Pubitemid 47208625)
37. Smith CC, Mocanu MM, Davidson SM, Wynne AM, Simpkin JC, Yellon DM. 2006. Leptin, the obesity-associated hormone, exhibits direct cardioprotective effects. Br J Pharmacol 149:5-13.
38. Sridharan V, Guichard J, Bailey RM, Kasiganesan H, Beeson C, Wright GL. 2007. The prolyl hydroxylase oxygen-sensing pathway is cytoprotective and allows maintenance of mitochondrial membrane potential during metabolic inhibition. Am J Physiol Cell Physiol 292:C719-C728. (Pubitemid 46263471)
39. Sweeney G. 2002. Leptin signalling. Cell Signal 14:655-663.
40. Webster KA. 2007. Programmed death as a therapeutic target to reduce myocardial infarction. Trends Pharmacol Sci 28:492-499. (Pubitemid 47368699)
41. Weng Z, Signore AP, Gao Y, Wang S, Zhang F, Hastings T, Yin XM, Chen J. 2007. Leptin protects against 6-hydroxydopamine-induced dopaminergic cell death via mitogen-activated protein kinase signaling. J Biol Chem 282:34479-34491. (Pubitemid 350159488)
42. Yamaji-Hasegawa A, Tsujimoto M. 2006. Asymmetric distribution of phospholipids in biomembranes. Biol Pharm Bull 29:1547-1553.
43. Zeidan A, Javadov S, Karmazyn M. 2006. Essential role of Rho/ROCK-dependent processes and actin dynamics in mediating leptin-induced hypertrophy in rat neonatal ventricular myocytes. Cardiovasc Res 72:101-111. (Pubitemid 44310635)
44. Zheng XL, Yuan SG, Peng DQ. 2007. Phenotype-specific inhibition of the vascular smooth muscle cell cycle by high glucose treatment. Diabetologia 50:881-890.